REQUEST FOR INFORMATION: ADAMTS13 Activity (P -ADAM13) Analysis

PURPOSE OF THE INFORMATION REQUEST The purpose of this information request is to investigate questions and cost estimates related to plasma P -ADAM13 analysis (ADAMTS13 activity, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13). The goal is to gather comprehensive information about available reagents and equipment …

CPV: 38000000 Laboratory, optical and precision equipments (excl. glasses), 33696500 Laboratory reagents
Place of execution:
REQUEST FOR INFORMATION: ADAMTS13 Activity (P -ADAM13) Analysis
Awarding body:
HUS Group
Award number:
HUS 746-2023

1. Buyer

1.1 Buyer

Official name : HUS Group
Legal type of the buyer : Regional authority
Activity of the contracting authority : Health

2. Procedure

2.1 Procedure

Title : REQUEST FOR INFORMATION: ADAMTS13 Activity (P -ADAM13) Analysis
Description : PURPOSE OF THE INFORMATION REQUEST The purpose of this information request is to investigate questions and cost estimates related to plasma P -ADAM13 analysis (ADAMTS13 activity, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13). The goal is to gather comprehensive information about available reagents and equipment (accessories, maintenance) to facilitate a potential future tender in the most appropriate manner. This document is not a procurement notice or a request for tender but a detailed market survey, i.e., an information request. The contracting authority is not committed to procuring the mentioned analysis. Decisions on initiating a potential procurement process will be made later after the market survey. BACKGROUND INFORMATION ON THE PROCUREMENT HUS Group (HUS) is the joint authority for Helsinki and Uusimaa, as referred to in the Act on Wellbeing Services Counties. It is tasked with providing its members and their residents with specialised healthcare services. More information about the procurement authority can be found in the "Other information" section. HUS Diagnostic Center’s Clinical Chemistry is exploring options for performing ADAMTS13 activity (ADAM13) analysis for future procurement. ADAM13 analysis is performed as an emergency test 24/7 at the HUS Diagnostic Center’s Automation Laboratory in the HUSLAB building in Helsinki. The procurement may include the device, maintenance contracts, reagents, device-specific accessories, and all other consumables and items needed to produce the mentioned analysis. The analysis is primarily intended to be performed as a random access-based assay. However, information is requested on all options for performing ADAM13 analysis for which the reagent supplier has a ready protocol. The procurement may include, if necessary: • CE-marked reagents including controls and calibrators and device-specific accessories, possible analyzers with software, periodic maintenance, necessary spare parts and accessories, technical support, possible software updates (maintenance contract if necessary), and product training if needed. • Necessary workstations and software and connections to the LIS interface must be available. QUESTIONS FOR COMPANIES We inquire about your views on the following matters: • Are you interested in offering? We ask you to present your views on the implementation options of the project. • Would you like to give a 60-minute Teams presentation of your solution proposal, which will be recorded for internal use by the HUS Diagnostic Center? • Preliminary price information • Describe your company’s experience in providing the services in question. We ask you to state how many references and what kind of references you have for providing services corresponding to the subject of the procurement. • We ask you to state a reference from a clinical laboratory where the offered analysis is in use in the European Economic Area (EEA). • How many similar devices have been installed in clinical laboratories in the EEA in the last five years? • Is there a service engineer for the offered analysis/device in Finland? What are the service response times? • Warranty and delivery times for devices and accessories? • Is your assay’s result level traceable to a standard? • What is the country of origin of your products? The response to this request for information should include replies to the above questions. Answers to questions should be submitted by 27.11.2024 at the latest to the email address: kilpailutus.laboratorio@hus.fi . The title or message field of the e-mail should mention: HUS 746-2023 ADAMTS13 Activity (P -ADAM13) Analysis. The costs associated with responding to a request for information are borne by the respondent, and HUS does not pay compensation for responding to a request for information or participating the procurement procedure.
Internal identifier : HUS 746-2023

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 38000000 Laboratory, optical and precision equipments (excl. glasses)
Additional classification ( cpv ): 33696500 Laboratory reagents

2.1.2 Place of performance

Anywhere

2.1.4 General information

Legal basis :
Directive 2014/24/EU

3. Part

3.1 Part technical ID : PAR-0000

Title : REQUEST FOR INFORMATION: ADAMTS13 Activity (P -ADAM13) Analysis
Description : PURPOSE OF THE INFORMATION REQUEST The purpose of this information request is to investigate questions and cost estimates related to plasma P -ADAM13 analysis (ADAMTS13 activity, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13). The goal is to gather comprehensive information about available reagents and equipment (accessories, maintenance) to facilitate a potential future tender in the most appropriate manner. This document is not a procurement notice or a request for tender but a detailed market survey, i.e., an information request. The contracting authority is not committed to procuring the mentioned analysis. Decisions on initiating a potential procurement process will be made later after the market survey. BACKGROUND INFORMATION ON THE PROCUREMENT HUS Group (HUS) is the joint authority for Helsinki and Uusimaa, as referred to in the Act on Wellbeing Services Counties. It is tasked with providing its members and their residents with specialised healthcare services. More information about the procurement authority can be found in the "Other information" section. HUS Diagnostic Center’s Clinical Chemistry is exploring options for performing ADAMTS13 activity (ADAM13) analysis for future procurement. ADAM13 analysis is performed as an emergency test 24/7 at the HUS Diagnostic Center’s Automation Laboratory in the HUSLAB building in Helsinki. The procurement may include the device, maintenance contracts, reagents, device-specific accessories, and all other consumables and items needed to produce the mentioned analysis. The analysis is primarily intended to be performed as a random access-based assay. However, information is requested on all options for performing ADAM13 analysis for which the reagent supplier has a ready protocol. The procurement may include, if necessary: • CE-marked reagents including controls and calibrators and device-specific accessories, possible analyzers with software, periodic maintenance, necessary spare parts and accessories, technical support, possible software updates (maintenance contract if necessary), and product training if needed. • Necessary workstations and software and connections to the LIS interface must be available. QUESTIONS FOR COMPANIES We inquire about your views on the following matters: • Are you interested in offering? We ask you to present your views on the implementation options of the project. • Would you like to give a 60-minute Teams presentation of your solution proposal, which will be recorded for internal use by the HUS Diagnostic Center? • Preliminary price information • Describe your company’s experience in providing the services in question. We ask you to state how many references and what kind of references you have for providing services corresponding to the subject of the procurement. • We ask you to state a reference from a clinical laboratory where the offered analysis is in use in the European Economic Area (EEA). • How many similar devices have been installed in clinical laboratories in the EEA in the last five years? • Is there a service engineer for the offered analysis/device in Finland? What are the service response times? • Warranty and delivery times for devices and accessories? • Is your assay’s result level traceable to a standard? • What is the country of origin of your products? The response to this request for information should include replies to the above questions. Answers to questions should be submitted by 27.11.2024 at the latest to the email address: kilpailutus.laboratorio@hus.fi . The title or message field of the e-mail should mention: HUS 746-2023 ADAMTS13 Activity (P -ADAM13) Analysis. The costs associated with responding to a request for information are borne by the respondent, and HUS does not pay compensation for responding to a request for information or participating the procurement procedure.
Internal identifier : 773135

3.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 38000000 Laboratory, optical and precision equipments (excl. glasses)
Additional classification ( cpv ): 33696500 Laboratory reagents

3.1.2 Place of performance

Anywhere

3.1.5 General information

Reserved participation : Participation is not reserved.
The procurement is covered by the Government Procurement Agreement (GPA) : yes

3.1.6 Procurement documents

Languages in which the procurement documents are officially available : English

3.1.7 Terms of procurement

The execution of the contract must be performed within the framework of sheltered employment programmes : No

3.1.9 Further information, mediation and review

Review organisation : Markkinaoikeus

8. Organisations

8.1 ORG-0001

Official name : Markkinaoikeus
Registration number : 3006157-6
Postal address : Radanrakentajantie 5
Town : Helsinki
Postcode : 00520
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : +358 295643300
Roles of this organisation :
Review organisation

8.1 ORG-0002

Official name : HUS Group
Registration number : 1567535-0
Postal address : Uutistie 5 (PO Box 441, 00029 HUS)
Town : Vantaa
Postcode : 01770
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : Laboratorio
Telephone : +358 94711
Internet address : http://www.hus.fi
Roles of this organisation :
Buyer

8.1 ORG-0003

Official name : Hansel Oy (Hilma)
Registration number : FI09880841
Postal address : Mannerheiminaukio 1a
Town : Helsinki
Postcode : 00100
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : eSender
Telephone : 029 55 636 30
Roles of this organisation :
TED eSender

11. Notice information

11.1 Notice information

Notice identifier/version : 56f79e12-ddd6-4826-801a-58e23c32a894 - 01
Form type : Planning
Notice type : Prior information notice or a periodic indicative notice used only for information
Notice dispatch date : 15/11/2024 12:03 +00:00
Notice dispatch date (eSender) : 15/11/2024 12:04 +00:00
Languages in which this notice is officially available : English

11.2 Publication information

Notice publication number : 00701109-2024
OJ S issue number : 224/2024
Publication date : 18/11/2024
Estimated date of publication of a contract notice within this procedure : 29/11/2024